Abstract:Reactive oxygen species (ROS) play a critical role in the pathogenesis of osteoarthritis. The injection of a single antioxidant drug is characterized by low drug utilization and short residence time in the articular cavity, limiting the therapeutic effect of antioxidant drugs on osteoarthritis. Currently, the drug circu-lation half-life can be extended using delivery vehicles such as liposomes and microspheres, which are widely used to treat diseases. In addition, the composite carriers of liposomes and hydrogel microspheres can combine the advantages of different material forms and show stronger plasticity and flexibility than traditional single carriers, which are expected to become new local drug delivery systems. Chondroitin sulfate, a sulfated glycosaminoglycan commonly found in native cartilage, has good antioxidant properties and degradability and is used to develop an injectable chondroitin sulfate hydrogel by covalent modifi-cation with photo-cross-linkable methacryloyl groups (ChsMA). Herein, ChsMA microgels anchored with liquiritin (LQ)-loaded liposomes (ChsMA@Lipo) were developed to delay the progression of osteoarthri-tis by dual antioxidation. On the one hand, the antioxidant drug LQ wrapped in ChsMA@Lipo microgels exhibits significant sustained-release kinetics due to the double obstruction of the lipid membrane and the hydrogel matrix network. On the other hand, ChsMA can eliminate ROS through degradation into chondroitin sulfate monomers by enzymes in vivo . Therefore, ChsMA@Lipo, as a degradable and dual an-tioxidant drug delivery platform, is a promising option for osteoarthritis treatment.Statement of significanceCompared with the traditional single carrier, the composite carriers of hydrogel microspheres and lipo-some can complement the advantages of different materials, which shows stronger plasticity and flexibil-ity, and is expected to become a new and efficient drug delivery system. ChsMA@Lipo not only attenuates IL-1 beta-induced ECM degradation in chondrocytes but also inhibits the M1 macrophages polarization and the inflammasome activation. The obtained ChsMA@Lipo alleviates the progression of osteoarthritis in vivo , which is promising for osteoarthritis treatment.(c) 2022 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

ROS-responsive PPGF nanofiber membrane as a drug delivery system for long-term drug release in attenuation of osteoarthritis

Ros-responsive nanocomposite scaffolds for sustained releasing puerarin to achieve chondroprotection in OA rats

Reactive Oxygen Species-Scavenging Nanoparticles Coated with Chondroitin Sulfate Protect Cartilage Against Osteoarthritis in Vivo

The ROS‐responsive Scavenger with Intrinsic Antioxidant Capability and Enhanced Immunomodulatory Effects for Cartilage Protection and Osteoarthritis Remission

Polydopamine-Pd nanozymes as potent ROS scavengers in combination with near-infrared irradiation for osteoarthritis treatment

Reactive Oxygen Species-Responsive and Scavenging Polyurethane Nanoparticles for Treatment of Osteoarthritis in Vivo

Intelligent dual responsive modified ZIF-8 nanoparticles for diagnosis and treatment of osteoarthritis

Chondroitin Sulfate Microspheres Anchored with Drug-Loaded Liposomes Play a Dual Antioxidant Role in the Treatment of Osteoarthritis

Polydopamine Nanoparticles As Dual-Task Platform For Osteoarthritis Therapy: A Scavenger For Reactive Oxygen Species And Regulator For Cellular Powerhouses

A Composite Nanomaterial with the Ability to Regulate Oxidative Stress and Anti‐inflammatory for the Treatment of Osteoarthritis

Reactive oxygen species (ROS)-responsive nanoprobe for bioimaging and targeting therapy of osteoarthritis

A Reactive Oxygen Species "Sweeper" Based on Hollow Mesopore Cerium Oxide Nanospheres for Targeted and Anti-Inflammatory Management of Osteoarthritis

Cartilage-targeting and Inflammatory-Responsive Nanocarriers for Effective Osteoarthritis Treatment Via Reactive Oxygen Species Scavenging and Anti-Angiogenesis

Application of the pH-Responsive PCL/PEG-Nar Nanofiber Membrane in the Treatment of Osteoarthritis

NIR-driven Polydopamine-Based Nanoenzymes As ROS Scavengers to Suppress Osteoarthritis Progression

Ultrasmall Prussian Blue Nanozyme Attenuates Osteoarthritis by Scavenging Reactive Oxygen Species and Regulating Macrophage Phenotype

An Injectable Hydrogel Dotted with Dexamethasone Acetate-Encapsulated Reactive Oxygen Species-Scavenging Micelles for Combinatorial Therapy of Osteoarthritis

A ROS-responsive microsphere capsule encapsulated with NADPH oxidase 4 inhibitor ameliorates macrophage inflammation and ferroptosis

Responsive Multi‐Arm PEG‐Modified COF Nanocomposites: Dynamic Photothermal, pH/ROS Dual‐Responsive, Targeted Carriers for Rheumatoid Arthritis Treatment

Intra-articular injection of platinum nanozyme-loaded silk fibroin/pullulan hydrogels relieves osteoarthritis through ROS scavenging and ferroptosis suppression

Self‐reinforced MOF‐based Nanogel Alleviates Osteoarthritis by Long‐acting Drug Release